Myotonic dystrophy
- PMID: 25037086
- PMCID: PMC4105852
- DOI: 10.1016/j.ncl.2014.04.011
Myotonic dystrophy
Abstract
Myotonic dystrophy (dystrophia myotonica, DM) is one of the most common lethal monogenic disorders in populations of European descent. DM type 1 was first described over a century ago. More recently, a second form of the disease, DM type 2 was recognized, which results from repeat expansion in a different gene. Both disorders have autosomal dominant inheritance and multisystem features, including myotonic myopathy, cataract, and cardiac conduction disease. This article reviews the clinical presentation and pathophysiology of DM and discusses current management and future potential for developing targeted therapies.
Keywords: Electrophysiology; Expanded DNA repeat; Myopathy; Myotonic dystrophy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Similar articles
-
Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.Am J Hum Genet. 2003 Oct;73(4):835-48. doi: 10.1086/378566. Epub 2003 Sep 10. Am J Hum Genet. 2003. PMID: 12970845 Free PMC article.
-
The myotonic dystrophies.Semin Neurol. 1999;19(1):25-33. doi: 10.1055/s-2008-1040823. Semin Neurol. 1999. PMID: 10711986 Review.
-
Myotonic dystrophy and proximal myotonic myophathy.J Neurol. 1999 May;246(5):334-8. doi: 10.1007/s004150050359. J Neurol. 1999. PMID: 10399862 Review.
-
Clinical aspects, molecular pathomechanisms and management of myotonic dystrophies.Acta Myol. 2013 Dec;32(3):154-65. Acta Myol. 2013. PMID: 24803843 Free PMC article. Review.
-
Myotonic dystrophy type 2 and modifier genes: an update on clinical and pathomolecular aspects.Neurol Sci. 2017 Apr;38(4):535-546. doi: 10.1007/s10072-016-2805-5. Epub 2017 Jan 11. Neurol Sci. 2017. PMID: 28078562 Review.
Cited by
-
Psychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophy.Cochrane Database Syst Rev. 2024 Nov 18;11(11):CD003218. doi: 10.1002/14651858.CD003218.pub3. Cochrane Database Syst Rev. 2024. PMID: 39555632 Review.
-
Ventricular stimulation in patients with myotonic dystrophy type 1 may not predict future ventricular arrhythmias.Heart Rhythm O2. 2024 Aug 9;5(10):698-704. doi: 10.1016/j.hroo.2024.08.001. eCollection 2024 Oct. Heart Rhythm O2. 2024. PMID: 39524047 Free PMC article.
-
Fetal Brain MRI Findings in Myotonic Dystrophy and Considerations for Prenatal Genetic Testing.Neurol Genet. 2024 Oct 4;10(6):e200171. doi: 10.1212/NXG.0000000000200171. eCollection 2024 Dec. Neurol Genet. 2024. PMID: 39444647 Free PMC article.
-
Alternative splicing dysregulation across tissue and therapeutic approaches in a mouse model of myotonic dystrophy type 1.Mol Ther Nucleic Acids. 2024 Sep 13;35(4):102338. doi: 10.1016/j.omtn.2024.102338. eCollection 2024 Dec 10. Mol Ther Nucleic Acids. 2024. PMID: 39391766 Free PMC article.
-
Molecular Pathology of Myotonic Dystrophy Type 1 in Iceland.Mol Genet Genomic Med. 2024 Oct;12(10):e70013. doi: 10.1002/mgg3.70013. Mol Genet Genomic Med. 2024. PMID: 39373365 Free PMC article.
References
-
- Siciliano G, Manca M, Gennarelli M, et al. Epidemiology of myotonic dystrophy in Italy: reapprisal after genetic diagnosis. Clin Genet. 2001;59:344–349. - PubMed
-
- Magee A, Nevin NC. The epidemiology of myotonic dystrophy in Northern Ireland. Community Genet. 1999;2:179–183. - PubMed
-
- Harper PS. Myotonic Dystrophy. W.B. Saunders Company; London: 2001.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
